Neutrophils and Lymphoid Chimerism After Adult Living-Related Liver Transplantation From a Homozygous Donor

• Published in: Transplantation proceedings 2005-12, Vol.37 (10), p.4386-4388
• Main Authors: Hajeer, A.H., Issa, S., Alaskar, A., Abdullah, K., Awad, M., Tbakhi, A., Alabdulkareem, A.
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Bone Marrow - pathology; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Histocompatibility Testing; Homozygote; Humans; Liver Transplantation - immunology; Liver Transplantation - pathology; Liver Transplantation - physiology; Living Donors; Lymphocytes - physiology; Male; Medical sciences; Middle Aged; Neutrophils - physiology; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Tissue, organ and graft immunology; Transplantation Chimera
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2005.11.006

Chimerism and graft-versus-host disease (GVHD) pose significant risks to liver transplant patients. The risk of chimerism and GVHD is higher among cases of living-related liver transplant (LRLT). Donors homozygous at all HLA loci carry a higher risk for GVHD. Herein we present a case of LRLT. The recipient suffered from end-stage liver disease and received a right lobe graft from his son. After 8 months posttransplant, the patient developed profound bone marrow depression. The patient was negative for CMV, Brucella, HHV6, HHV8, HBV, HCV, and parvovirus. No skin or GI signs of GVHD were noted. The patient and donor were HLA typed by SSP. The donor was homozygous for all HLA loci while the patient shared the class II homozygosity and was class I heterozygous. Chimerism studies were prompted after noting that the neutrophil compartment of the patient was homozygous for all HLA loci. This initiated further studies of the PMN and lymphocytes by microsatellite analysis. A total 15 microsatellites were analyzed. The results suggest that the majority (75%) of the PMNs and 45% of the lymphocytes were of donor origin. The patient was treated with G-CSF; his WBC counts returned to normal. At 2.5 years posttransplant the patient had not developed GVHD, despite the large number of donor lymphocytes circulating in his bloodstream. The only complaint he had was severe arthritis, which was treated with steroids. It must be investigated whether this was the result of GVHD.